Home > Press Releases > Pet Arthritis Treatment Market

Pet Arthritis Treatment Market Likely to Surpass USD 7.1 Billion by 2035

Report Code: HC-76883  |  Published in: Mar 2026, By MarketGenics  |  Number of pages: 303
Get PDF
Buy

Global Pet Arthritis Treatment Market Forecast 2035:

According to the report, the global pet arthritis treatment market is projected to expand from USD 3.5 billion in 2025 to USD 7.1 billion by 2035, registering a CAGR of 7.4%, the highest during the forecast period. The pet arthritis treatment market is experiencing a massive growth due to the rise in the osteoarthritis and the other degenerative joint disorders in companion animals. The increased awareness of the owners on early diagnosis and proactive management of arthritis has increased the use of both the conventional therapy, including NSAIDs, and the advanced therapy, including biologics and regenerative medicine. With the development of better veterinary care alongside the introduction of targeted therapies, development of drug formulations and customized treatment, the efficacy of treatment and compliance are also being improved, as well as the health of the pet.

The combination of digital health solutions, wearable monitoring devices, and telehealth platforms allow constant monitoring of mobility, activity, and pain symptoms to make possible the timely effect and more effective management of the disease. There is also the introduction of holistic and alternative therapies that are being integrated into the multifaceted arthritis care plan including nutraceuticals, physical therapies and acupuncture. The expansion of the market is still driven by rising spending on research and development, new product lines, and the need to ensure the aging pets maintain high quality of life.

“Key Driver, Restraint, and Growth Opportunity Shaping the Global Pet Arthritis Treatment Market”

The increasing awareness of pet owners regarding joint health, mobility, and early arthritis signs is a major cause of the pet arthritis treatment market. Veterinarian, pet care organizations and online educational campaigns promote the timely diagnosis and proactive control. The more informed the owners are, the more they are interested in preventive care, frequent screening and good treatment choices, which hastens the uptake of arthritis therapies.

Advanced arthritis treatments, such as biologics, regenerative treatments, and surgery are expensive, which is a limiting factor to their use in the pet arthritis treatment market. The lack of insurance coverage results in high out of pocket costs among many of the pet owners especially in those regions that are price sensitive. This high cost may slow down the decision-making process where the treatment is concerned, limit access to new treatments and limit the development of the market in general.

A major opportunity in the pet arthritis treatment market is the increasing demand of personalized treatment strategies and integrated treatment strategies. Integrating medications, vitamin and mineral supplements, exercise, and electronic monitoring health devices enable veterinarians to provide unique care plans to meet personal pet requirements. This holistic practice boosts the effectiveness of the treatment, advances the mobility of the pet, and its quality of life, elevates the satisfaction and compliance of the owner to the long-term arthritis management.

Expansion of Global Pet Arthritis Treatment Market

“Innovation that propel the global pet arthritis treatment market expansion”

  • The pet arthritis treatment market has been growing at a fast rate owing to the increasing cases of osteoarthritis in old pets, the subsequent rise in pet ownership, and the awareness of animal health and wellness. Veterinary medicine, biologics, regenerative therapy and customized treatment regimens are advancing and are increasing the number of treatment options.
  • Also, the implementation of telehealth, online monitoring devices, and integrative care strategies contribute further to the diagnosis of the disease in its early stages, better treatment adherence, and increased quality of life of pets, which prompts the continuous market growth at the international level.

Regional Analysis of Global Pet Arthritis Treatment Market

  • North America leads the pet arthritis treatment market due to high pet ownership rates, strong spending on pet healthcare, and well-established veterinary infrastructure. Pet owners increasingly prioritize early diagnosis and effective management of arthritis, driving demand for both traditional treatments like NSAIDs and advanced biologics or regenerative therapies. Widespread awareness campaigns, educational initiatives, and easy access to innovative treatment options further strengthen the region’s market dominance, making North America a key driver of global growth in pet arthritis care.
  • The Asia Pacific pet arthritis treatment market is experiencing rapid growth, driven by rising pet adoption, increasing disposable incomes, and growing awareness of animal health and wellness. Expanding veterinary infrastructure, availability of advanced therapies, and the adoption of preventive and long-term arthritis management solutions contribute to market expansion. Additionally, emerging trends such as biologics, regenerative medicine, and telehealth platforms are supporting early diagnosis and improved treatment outcomes, further fueling demand for effective pet arthritis care across the region.

Prominent players operating in the global pet arthritis treatment market are Adequan (American Regent Animal Health), Boehringer Ingelheim Animal Health, Ceva Santé Animale, Chanelle Pharma, Dechra Pharmaceuticals PLC, Elanco Animal Health, Kindred Biosciences Inc., Merck Animal Health, Nexvet Biopharma, Norbrook Laboratories Limited, Nutramax Laboratories Veterinary Sciences, VetGen Pharmaceuticals, Vetoquinol S.A., Virbac S.A., Zoetis Inc., Other Key Players.

The global pet arthritis treatment market has been segmented as follows:

Global Pet Arthritis Treatment Market Analysis, By Product Type

  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    • COX-2 Selective Inhibitors
    • Non-Selective NSAIDs
  • Disease-Modifying Osteoarthritis Drugs (DMOADs)
    • Chondroprotective Agents
    • Regenerative Medicine Products
  • Nutraceuticals & Supplements
    • Glucosamine-based Products
    • Chondroitin Sulfate Products
    • Omega-3 Fatty Acids
    • Combination Supplements
  • Corticosteroids
    • Injectable Formulations
    • Oral Formulations
  • Viscosupplementation Products
    • Hyaluronic Acid Injections
    • Polysulfated Glycosaminoglycans
  • Physical Therapy Devices
    • Laser Therapy Equipment
    • Ultrasound Therapy Devices
    • Electromagnetic Field Therapy Devices

Global Pet Arthritis Treatment Market Analysis, By Animal Type

  • Dogs
    • Small Breeds (<25 lbs)
    • Medium Breeds (25-50 lbs)
    • Large Breeds (>50 lbs)
  • Cats
  • Horses
  • Other Companion Animals

Global Pet Arthritis Treatment Market Analysis, By Route of Administration

  • Oral
    • Tablets
    • Capsules
    • Chewables
    • Liquids/Suspensions
    • Others
  • Injectable
    • Intravenous
    • Intramuscular
    • Intra-articular
    • Subcutaneous
  • Topical
    • Creams
    • Gels
    • Sprays
    • Others

Global Pet Arthritis Treatment Market Analysis, By Distribution Channel

  • Veterinary Hospitals & Clinics
    • Specialty Veterinary Centers
    • General Practice Clinics
  • Veterinary Pharmacies
    • Independent Pharmacies
    • Chain Pharmacies
  • Online Pharmacies & E-commerce Platforms
  • Retail Stores
    • Pet Specialty Stores
    • Mass Merchandisers
    • Supermarkets

Global Pet Arthritis Treatment Market Analysis, By Treatment Stage

  • Acute Treatment
  • Chronic Management
  • Preventive Care
  • Post-Surgical Recovery

Global Pet Arthritis Treatment Market Analysis, By Therapy Type

  • Monotherapy
  • Combination Therapy
    • Drug-Drug Combinations
    • Drug-Device Combinations
    • Integrative Therapy Approaches

Global Pet Arthritis Treatment Market Analysis, By Prescription Type

  • Prescription-Only Medications
  • Over-the-Counter (OTC) Products
  • Veterinary Feed Directive (VFD) Products

Global Pet Arthritis Treatment Market Analysis, By End-use

  • Veterinary Healthcare Services
  • Veterinary Pharmaceuticals
  • Animal Nutrition & Supplement
  • Veterinary Medical Devices
  • Pet Insurance
  • Animal Research & Development
  • Others

Global Pet Arthritis Treatment Market Analysis, By Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • South America

​About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact Us

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

  • 1. Research Methodology and Assumptions
    • 1.1. Definitions
    • 1.2. Research Design and Approach
    • 1.3. Data Collection Methods
    • 1.4. Base Estimates and Calculations
    • 1.5. Forecasting Models
      • 1.5.1. Key Forecast Factors & Impact Analysis
    • 1.6. Secondary Research
      • 1.6.1. Open Sources
      • 1.6.2. Paid Databases
      • 1.6.3. Associations
    • 1.7. Primary Research
      • 1.7.1. Primary Sources
      • 1.7.2. Primary Interviews with Stakeholders across Ecosystem
  • 2. Executive Summary
    • 2.1. Global Pet Arthritis Treatment Market Outlook
      • 2.1.1. Pet Arthritis Treatment Market Size Value (US$ Bn), and Forecasts, 2021-2035
      • 2.1.2. Compounded Annual Growth Rate Analysis
      • 2.1.3. Growth Opportunity Analysis
      • 2.1.4. Segmental Share Analysis
      • 2.1.5. Geographical Share Analysis
    • 2.2. Market Analysis and Facts
    • 2.3. Supply-Demand Analysis
    • 2.4. Competitive Benchmarking
    • 2.5. Go-to- Market Strategy
      • 2.5.1. Customer/ End-use Industry Assessment
      • 2.5.2. Growth Opportunity Data, 2026-2035
        • 2.5.2.1. Regional Data
        • 2.5.2.2. Country Data
        • 2.5.2.3. Segmental Data
      • 2.5.3. Identification of Potential Market Spaces
      • 2.5.4. GAP Analysis
      • 2.5.5. Potential Attractive Price Points
      • 2.5.6. Prevailing Market Risks & Challenges
      • 2.5.7. Preferred Sales & Marketing Strategies
      • 2.5.8. Key Recommendations and Analysis
      • 2.5.9. A Way Forward
  • 3. Industry Data and Premium Insights
    • 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
      • 3.1.1. Healthcare & Pharmaceutical Industry Ecosystem Analysis
      • 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
      • 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
    • 3.2. Supplier Customer Data
    • 3.3. Technology Roadmap and Developments
    • 3.4. Trade Analysis
      • 3.4.1. Import & Export Analysis, 2025
      • 3.4.2. Top Importing Countries
      • 3.4.3. Top Exporting Countries
    • 3.5. Trump Tariff Impact Analysis
      • 3.5.1. Manufacturer
        • 3.5.1.1. Based on the component & Raw material
      • 3.5.2. Supply Chain
      • 3.5.3. End Consumer
    • 3.6. Raw Material Analysis
  • 4. Market Overview
    • 4.1. Market Dynamics
      • 4.1.1. Drivers
        • 4.1.1.1. Rising prevalence of osteoarthritis in aging companion animals
        • 4.1.1.2. Increasing pet healthcare spending and humanization of pets
        • 4.1.1.3. Growing availability of advanced therapies such as biologics and regenerative treatments
      • 4.1.2. Restraints
        • 4.1.2.1. Safety concerns associated with long-term NSAID use
        • 4.1.2.2. High cost of advanced and regenerative arthritis therapies
    • 4.2. Key Trend Analysis
    • 4.3. Regulatory Framework
      • 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
      • 4.3.2. Tariffs and Standards
      • 4.3.3. Impact Analysis of Regulations on the Market
    • 4.4. Value Chain Analysis
      • 4.4.1. Raw Material Suppliers
      • 4.4.2. Active Pharmaceutical Ingredient (API) Manufacturers
      • 4.4.3. Distribution Channels
      • 4.4.4. Pet Owners / End Users
    • 4.5. Porter’s Five Forces Analysis
    • 4.6. PESTEL Analysis
    • 4.7. Global Pet Arthritis Treatment Market Demand
      • 4.7.1. Historical Market Size – Value (US$ Bn), 2020-2024
      • 4.7.2. Current and Future Market Size – Value (US$ Bn), 2026–2035
        • 4.7.2.1. Y-o-Y Growth Trends
        • 4.7.2.2. Absolute $ Opportunity Assessment
  • 5. Competition Landscape
    • 5.1. Competition structure
      • 5.1.1. Fragmented v/s consolidated
    • 5.2. Company Share Analysis, 2025
      • 5.2.1. Global Company Market Share
      • 5.2.2. By Region
        • 5.2.2.1. North America
        • 5.2.2.2. Europe
        • 5.2.2.3. Asia Pacific
        • 5.2.2.4. Middle East
        • 5.2.2.5. Africa
        • 5.2.2.6. South America
    • 5.3. Product Comparison Matrix
      • 5.3.1. Specifications
      • 5.3.2. Market Positioning
      • 5.3.3. Pricing
  • 6. Global Pet Arthritis Treatment Market Analysis, by Product Type
    • 6.1. Key Segment Analysis
    • 6.2. Pet Arthritis Treatment Market Size Value (US$ Bn), Analysis, and Forecasts, by Product Type, 2021-2035
      • 6.2.1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
        • 6.2.1.1. COX-2 Selective Inhibitors
        • 6.2.1.2. Non-Selective NSAIDs
      • 6.2.2. Disease-Modifying Osteoarthritis Drugs (DMOADs)
        • 6.2.2.1. Chondroprotective Agents
        • 6.2.2.2. Regenerative Medicine Products
      • 6.2.3. Nutraceuticals & Supplements
        • 6.2.3.1. Glucosamine-based Products
        • 6.2.3.2. Chondroitin Sulfate Products
        • 6.2.3.3. Omega-3 Fatty Acids
        • 6.2.3.4. Combination Supplements
      • 6.2.4. Corticosteroids
        • 6.2.4.1. Injectable Formulations
        • 6.2.4.2. Oral Formulations
      • 6.2.5. Viscosupplementation Products
        • 6.2.5.1. Hyaluronic Acid Injections
        • 6.2.5.2. Polysulfated Glycosaminoglycans
      • 6.2.6. Physical Therapy Devices
        • 6.2.6.1. Laser Therapy Equipment
        • 6.2.6.2. Ultrasound Therapy Devices
        • 6.2.6.3. Electromagnetic Field Therapy Devices
  • 7. Global Pet Arthritis Treatment Market Analysis, by Animal Type
    • 7.1. Key Segment Analysis
    • 7.2. Pet Arthritis Treatment Market Size Value (US$ Bn), Analysis, and Forecasts, by Animal Type, 2021-2035
      • 7.2.1. Dogs
        • 7.2.1.1. Small Breeds (<25 lbs)
        • 7.2.1.2. Medium Breeds (25-50 lbs)
        • 7.2.1.3. Large Breeds (>50 lbs)
      • 7.2.2. Cats
      • 7.2.3. Horses
      • 7.2.4. Other Companion Animals
  • 8. Global Pet Arthritis Treatment Market Analysis, by Route of Administration
    • 8.1. Key Segment Analysis
    • 8.2. Pet Arthritis Treatment Market Size Value (US$ Bn), Analysis, and Forecasts, by Route of Administration, 2021-2035
      • 8.2.1. Oral
        • 8.2.1.1. Tablets
        • 8.2.1.2. Capsules
        • 8.2.1.3. Chewables
        • 8.2.1.4. Liquids/Suspensions
        • 8.2.1.5. Others
      • 8.2.2. Injectable
        • 8.2.2.1. Intravenous
        • 8.2.2.2. Intramuscular
        • 8.2.2.3. Intra-articular
        • 8.2.2.4. Subcutaneous
      • 8.2.3. Topical
        • 8.2.3.1. Creams
        • 8.2.3.2. Gels
        • 8.2.3.3. Sprays
        • 8.2.3.4. Others
  • 9. Global Pet Arthritis Treatment Market Analysis, by Distribution Channel
    • 9.1. Key Segment Analysis
    • 9.2. Pet Arthritis Treatment Market Size Value (US$ Bn), Analysis, and Forecasts, by Distribution Channel, 2021-2035
      • 9.2.1. Veterinary Hospitals & Clinics
        • 9.2.1.1. Specialty Veterinary Centers
        • 9.2.1.2. General Practice Clinics
      • 9.2.2. Veterinary Pharmacies
        • 9.2.2.1. Independent Pharmacies
        • 9.2.2.2. Chain Pharmacies
      • 9.2.3. Online Pharmacies & E-commerce Platforms
      • 9.2.4. Retail Stores
        • 9.2.4.1. Pet Specialty Stores
        • 9.2.4.2. Mass Merchandisers
        • 9.2.4.3. Supermarkets
  • 10. Global Pet Arthritis Treatment Market Analysis, by Treatment Stage
    • 10.1. Key Segment Analysis
    • 10.2. Pet Arthritis Treatment Market Size Value (US$ Bn), Analysis, and Forecasts, by Treatment Stage, 2021-2035
      • 10.2.1. Acute Treatment
      • 10.2.2. Chronic Management
      • 10.2.3. Preventive Care
      • 10.2.4. Post-Surgical Recovery
  • 11. Global Pet Arthritis Treatment Market Analysis, by Therapy Type
    • 11.1. Key Segment Analysis
    • 11.2. Pet Arthritis Treatment Market Size Value (US$ Bn), Analysis, and Forecasts, by Therapy Type, 2021-2035
      • 11.2.1. Monotherapy
      • 11.2.2. Combination Therapy
        • 11.2.2.1. Drug-Drug Combinations
        • 11.2.2.2. Drug-Device Combinations
        • 11.2.2.3. Integrative Therapy Approaches
  • 12. Global Pet Arthritis Treatment Market Analysis, by Prescription Type
    • 12.1. Key Segment Analysis
    • 12.2. Pet Arthritis Treatment Market Size Value (US$ Bn), Analysis, and Forecasts, by Prescription Type, 2021-2035
      • 12.2.1. Prescription-Only Medications
      • 12.2.2. Over-the-Counter (OTC) Products
      • 12.2.3. Veterinary Feed Directive (VFD) Products
  • 13. Global Pet Arthritis Treatment Market Analysis and Forecasts, by Distribution Channel
    • 13.1. Key Findings
    • 13.2. Pet Arthritis Treatment Market Size Value (US$ Bn), Analysis, and Forecasts, by End-use, 2021-2035
      • 13.2.1. Veterinary Healthcare Services
      • 13.2.2. Veterinary Pharmaceuticals
      • 13.2.3. Animal Nutrition & Supplement
      • 13.2.4. Veterinary Medical Devices
      • 13.2.5. Pet Insurance
      • 13.2.6. Animal Research & Development
      • 13.2.7. Others
  • 14. Global Pet Arthritis Treatment Market Analysis and Forecasts, by Region
    • 14.1. Key Findings
    • 14.2. Pet Arthritis Treatment Market Size Value (US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
      • 14.2.1. North America
      • 14.2.2. Europe
      • 14.2.3. Asia Pacific
      • 14.2.4. Middle East
      • 14.2.5. Africa
      • 14.2.6. South America
  • 15. North America Pet Arthritis Treatment Market Analysis
    • 15.1. Key Segment Analysis
    • 15.2. Regional Snapshot
    • 15.3. North America Pet Arthritis Treatment Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 15.3.1. Product Type
      • 15.3.2. Animal Type
      • 15.3.3. Route of Administration
      • 15.3.4. Distribution Channel
      • 15.3.5. Treatment Stage
      • 15.3.6. Therapy Type
      • 15.3.7. Prescription Type
      • 15.3.8. End-use
      • 15.3.9. Country
        • 15.3.9.1. USA
        • 15.3.9.2. Canada
        • 15.3.9.3. Mexico
    • 15.4. USA Pet Arthritis Treatment Market
      • 15.4.1. Country Segmental Analysis
      • 15.4.2. Product Type
      • 15.4.3. Animal Type
      • 15.4.4. Route of Administration
      • 15.4.5. Distribution Channel
      • 15.4.6. Treatment Stage
      • 15.4.7. Therapy Type
      • 15.4.8. Prescription Type
      • 15.4.9. End-use
    • 15.5. Canada Pet Arthritis Treatment Market
      • 15.5.1. Country Segmental Analysis
      • 15.5.2. Product Type
      • 15.5.3. Animal Type
      • 15.5.4. Route of Administration
      • 15.5.5. Distribution Channel
      • 15.5.6. Treatment Stage
      • 15.5.7. Therapy Type
      • 15.5.8. Prescription Type
      • 15.5.9. End-use
    • 15.6. Mexico Pet Arthritis Treatment Market
      • 15.6.1. Country Segmental Analysis
      • 15.6.2. Product Type
      • 15.6.3. Animal Type
      • 15.6.4. Route of Administration
      • 15.6.5. Distribution Channel
      • 15.6.6. Treatment Stage
      • 15.6.7. Therapy Type
      • 15.6.8. Prescription Type
      • 15.6.9. End-use
  • 16. Europe Pet Arthritis Treatment Market Analysis
    • 16.1. Key Segment Analysis
    • 16.2. Regional Snapshot
    • 16.3. Europe Pet Arthritis Treatment Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 16.3.1. Monitoring Type
      • 16.3.2. Product Type
      • 16.3.3. Animal Type
      • 16.3.4. Route of Administration
      • 16.3.5. Distribution Channel
      • 16.3.6. Treatment Stage
      • 16.3.7. Therapy Type
      • 16.3.8. Prescription Type
      • 16.3.9. End-use
      • 16.3.10. Country
        • 16.3.10.1. Germany
        • 16.3.10.2. United Kingdom
        • 16.3.10.3. France
        • 16.3.10.4. Italy
        • 16.3.10.5. Spain
        • 16.3.10.6. Netherlands
        • 16.3.10.7. Nordic Countries
        • 16.3.10.8. Poland
        • 16.3.10.9. Russia & CIS
        • 16.3.10.10. Rest of Europe
    • 16.4. Germany Pet Arthritis Treatment Market
      • 16.4.1. Country Segmental Analysis
      • 16.4.2. Product Type
      • 16.4.3. Animal Type
      • 16.4.4. Route of Administration
      • 16.4.5. Distribution Channel
      • 16.4.6. Treatment Stage
      • 16.4.7. Therapy Type
      • 16.4.8. Prescription Type
      • 16.4.9. End-use
    • 16.5. United Kingdom Pet Arthritis Treatment Market
      • 16.5.1. Country Segmental Analysis
      • 16.5.2. Product Type
      • 16.5.3. Animal Type
      • 16.5.4. Route of Administration
      • 16.5.5. Distribution Channel
      • 16.5.6. Treatment Stage
      • 16.5.7. Therapy Type
      • 16.5.8. Prescription Type
      • 16.5.9. End-use
    • 16.6. France Pet Arthritis Treatment Market
      • 16.6.1. Country Segmental Analysis
      • 16.6.2. Product Type
      • 16.6.3. Animal Type
      • 16.6.4. Route of Administration
      • 16.6.5. Distribution Channel
      • 16.6.6. Treatment Stage
      • 16.6.7. Therapy Type
      • 16.6.8. Prescription Type
      • 16.6.9. End-use
    • 16.7. Italy Pet Arthritis Treatment Market
      • 16.7.1. Country Segmental Analysis
      • 16.7.2. Product Type
      • 16.7.3. Animal Type
      • 16.7.4. Route of Administration
      • 16.7.5. Distribution Channel
      • 16.7.6. Treatment Stage
      • 16.7.7. Therapy Type
      • 16.7.8. Prescription Type
      • 16.7.9. End-use
    • 16.8. Spain Pet Arthritis Treatment Market
      • 16.8.1. Country Segmental Analysis
      • 16.8.2. Product Type
      • 16.8.3. Animal Type
      • 16.8.4. Route of Administration
      • 16.8.5. Distribution Channel
      • 16.8.6. Treatment Stage
      • 16.8.7. Therapy Type
      • 16.8.8. Prescription Type
      • 16.8.9. End-use
    • 16.9. Netherlands Pet Arthritis Treatment Market
      • 16.9.1. Country Segmental Analysis
      • 16.9.2. Product Type
      • 16.9.3. Animal Type
      • 16.9.4. Route of Administration
      • 16.9.5. Distribution Channel
      • 16.9.6. Treatment Stage
      • 16.9.7. Therapy Type
      • 16.9.8. Prescription Type
      • 16.9.9. End-use
    • 16.10. Nordic Countries Pet Arthritis Treatment Market
      • 16.10.1. Country Segmental Analysis
      • 16.10.2. Product Type
      • 16.10.3. Animal Type
      • 16.10.4. Route of Administration
      • 16.10.5. Distribution Channel
      • 16.10.6. Treatment Stage
      • 16.10.7. Therapy Type
      • 16.10.8. Prescription Type
      • 16.10.9. End-use
    • 16.11. Poland Pet Arthritis Treatment Market
      • 16.11.1. Country Segmental Analysis
      • 16.11.2. Product Type
      • 16.11.3. Animal Type
      • 16.11.4. Route of Administration
      • 16.11.5. Distribution Channel
      • 16.11.6. Treatment Stage
      • 16.11.7. Therapy Type
      • 16.11.8. Prescription Type
      • 16.11.9. End-use
    • 16.12. Russia & CIS Pet Arthritis Treatment Market
      • 16.12.1. Country Segmental Analysis
      • 16.12.2. Product Type
      • 16.12.3. Animal Type
      • 16.12.4. Route of Administration
      • 16.12.5. Distribution Channel
      • 16.12.6. Treatment Stage
      • 16.12.7. Therapy Type
      • 16.12.8. Prescription Type
      • 16.12.9. End-use
    • 16.13. Rest of Europe Pet Arthritis Treatment Market
      • 16.13.1. Country Segmental Analysis
      • 16.13.2. Product Type
      • 16.13.3. Animal Type
      • 16.13.4. Route of Administration
      • 16.13.5. Distribution Channel
      • 16.13.6. Treatment Stage
      • 16.13.7. Therapy Type
      • 16.13.8. Prescription Type
      • 16.13.9. End-use
  • 17. Asia Pacific Pet Arthritis Treatment Market Analysis
    • 17.1. Key Segment Analysis
    • 17.2. Regional Snapshot
    • 17.3. Asia Pacific Pet Arthritis Treatment Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 17.3.1. Product Type
      • 17.3.2. Animal Type
      • 17.3.3. Route of Administration
      • 17.3.4. Distribution Channel
      • 17.3.5. Treatment Stage
      • 17.3.6. Therapy Type
      • 17.3.7. Prescription Type
      • 17.3.8. End-use
      • 17.3.9. Country
        • 17.3.9.1. China
        • 17.3.9.2. India
        • 17.3.9.3. Japan
        • 17.3.9.4. South Korea
        • 17.3.9.5. Australia and New Zealand
        • 17.3.9.6. Indonesia
        • 17.3.9.7. Malaysia
        • 17.3.9.8. Thailand
        • 17.3.9.9. Vietnam
        • 17.3.9.10. Rest of Asia Pacific
    • 17.4. China Pet Arthritis Treatment Market
      • 17.4.1. Country Segmental Analysis
      • 17.4.2. Product Type
      • 17.4.3. Animal Type
      • 17.4.4. Route of Administration
      • 17.4.5. Distribution Channel
      • 17.4.6. Treatment Stage
      • 17.4.7. Therapy Type
      • 17.4.8. Prescription Type
      • 17.4.9. End-use
    • 17.5. India Pet Arthritis Treatment Market
      • 17.5.1. Country Segmental Analysis
      • 17.5.2. Product Type
      • 17.5.3. Animal Type
      • 17.5.4. Route of Administration
      • 17.5.5. Distribution Channel
      • 17.5.6. Treatment Stage
      • 17.5.7. Therapy Type
      • 17.5.8. Prescription Type
      • 17.5.9. End-use
    • 17.6. Japan Pet Arthritis Treatment Market
      • 17.6.1. Country Segmental Analysis
      • 17.6.2. Product Type
      • 17.6.3. Animal Type
      • 17.6.4. Route of Administration
      • 17.6.5. Distribution Channel
      • 17.6.6. Treatment Stage
      • 17.6.7. Therapy Type
      • 17.6.8. Prescription Type
      • 17.6.9. End-use
    • 17.7. South Korea Pet Arthritis Treatment Market
      • 17.7.1. Country Segmental Analysis
      • 17.7.2. Product Type
      • 17.7.3. Animal Type
      • 17.7.4. Route of Administration
      • 17.7.5. Distribution Channel
      • 17.7.6. Treatment Stage
      • 17.7.7. Therapy Type
      • 17.7.8. Prescription Type
      • 17.7.9. End-use
    • 17.8. Australia and New Zealand Pet Arthritis Treatment Market
      • 17.8.1. Country Segmental Analysis
      • 17.8.2. Product Type
      • 17.8.3. Animal Type
      • 17.8.4. Route of Administration
      • 17.8.5. Distribution Channel
      • 17.8.6. Treatment Stage
      • 17.8.7. Therapy Type
      • 17.8.8. Prescription Type
      • 17.8.9. End-use
    • 17.9. Indonesia Pet Arthritis Treatment Market
      • 17.9.1. Country Segmental Analysis
      • 17.9.2. Product Type
      • 17.9.3. Animal Type
      • 17.9.4. Route of Administration
      • 17.9.5. Distribution Channel
      • 17.9.6. Treatment Stage
      • 17.9.7. Therapy Type
      • 17.9.8. Prescription Type
      • 17.9.9. End-use
    • 17.10. Malaysia Pet Arthritis Treatment Market
      • 17.10.1. Country Segmental Analysis
      • 17.10.2. Product Type
      • 17.10.3. Animal Type
      • 17.10.4. Route of Administration
      • 17.10.5. Distribution Channel
      • 17.10.6. Treatment Stage
      • 17.10.7. Therapy Type
      • 17.10.8. Prescription Type
      • 17.10.9. End-use
    • 17.11. Thailand Pet Arthritis Treatment Market
      • 17.11.1. Country Segmental Analysis
      • 17.11.2. Product Type
      • 17.11.3. Animal Type
      • 17.11.4. Route of Administration
      • 17.11.5. Distribution Channel
      • 17.11.6. Treatment Stage
      • 17.11.7. Therapy Type
      • 17.11.8. Prescription Type
      • 17.11.9. End-use
    • 17.12. Vietnam Pet Arthritis Treatment Market
      • 17.12.1. Country Segmental Analysis
      • 17.12.2. Product Type
      • 17.12.3. Animal Type
      • 17.12.4. Route of Administration
      • 17.12.5. Distribution Channel
      • 17.12.6. Treatment Stage
      • 17.12.7. Therapy Type
      • 17.12.8. Prescription Type
      • 17.12.9. End-use
    • 17.13. Rest of Asia Pacific Pet Arthritis Treatment Market
      • 17.13.1. Country Segmental Analysis
      • 17.13.2. Product Type
      • 17.13.3. Animal Type
      • 17.13.4. Route of Administration
      • 17.13.5. Distribution Channel
      • 17.13.6. Treatment Stage
      • 17.13.7. Therapy Type
      • 17.13.8. Prescription Type
      • 17.13.9. End-use
  • 18. Middle East Pet Arthritis Treatment Market Analysis
    • 18.1. Key Segment Analysis
    • 18.2. Regional Snapshot
    • 18.3. Middle East Pet Arthritis Treatment Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 18.3.1. Product Type
      • 18.3.2. Animal Type
      • 18.3.3. Route of Administration
      • 18.3.4. Distribution Channel
      • 18.3.5. Treatment Stage
      • 18.3.6. Therapy Type
      • 18.3.7. Prescription Type
      • 18.3.8. End-use
      • 18.3.9. Country
        • 18.3.9.1. Turkey
        • 18.3.9.2. UAE
        • 18.3.9.3. Saudi Arabia
        • 18.3.9.4. Israel
        • 18.3.9.5. Rest of Middle East
    • 18.4. Turkey Pet Arthritis Treatment Market
      • 18.4.1. Country Segmental Analysis
      • 18.4.2. Product Type
      • 18.4.3. Animal Type
      • 18.4.4. Route of Administration
      • 18.4.5. Distribution Channel
      • 18.4.6. Treatment Stage
      • 18.4.7. Therapy Type
      • 18.4.8. Prescription Type
      • 18.4.9. End-use
    • 18.5. UAE Pet Arthritis Treatment Market
      • 18.5.1. Country Segmental Analysis
      • 18.5.2. Product Type
      • 18.5.3. Animal Type
      • 18.5.4. Route of Administration
      • 18.5.5. Distribution Channel
      • 18.5.6. Treatment Stage
      • 18.5.7. Therapy Type
      • 18.5.8. Prescription Type
      • 18.5.9. End-use
    • 18.6. Saudi Arabia Pet Arthritis Treatment Market
      • 18.6.1. Country Segmental Analysis
      • 18.6.2. Product Type
      • 18.6.3. Animal Type
      • 18.6.4. Route of Administration
      • 18.6.5. Distribution Channel
      • 18.6.6. Treatment Stage
      • 18.6.7. Therapy Type
      • 18.6.8. Prescription Type
      • 18.6.9. End-use
    • 18.7. Israel Pet Arthritis Treatment Market
      • 18.7.1. Country Segmental Analysis
      • 18.7.2. Product Type
      • 18.7.3. Animal Type
      • 18.7.4. Route of Administration
      • 18.7.5. Distribution Channel
      • 18.7.6. Treatment Stage
      • 18.7.7. Therapy Type
      • 18.7.8. Prescription Type
      • 18.7.9. End-use
    • 18.8. Rest of Middle East Pet Arthritis Treatment Market
      • 18.8.1. Country Segmental Analysis
      • 18.8.2. Product Type
      • 18.8.3. Animal Type
      • 18.8.4. Route of Administration
      • 18.8.5. Distribution Channel
      • 18.8.6. Treatment Stage
      • 18.8.7. Therapy Type
      • 18.8.8. Prescription Type
      • 18.8.9. End-use
  • 19. Africa Pet Arthritis Treatment Market Analysis
    • 19.1. Key Segment Analysis
    • 19.2. Regional Snapshot
    • 19.3. Africa Pet Arthritis Treatment Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 19.3.1. Product Type
      • 19.3.2. Animal Type
      • 19.3.3. Route of Administration
      • 19.3.4. Distribution Channel
      • 19.3.5. Treatment Stage
      • 19.3.6. Therapy Type
      • 19.3.7. Prescription Type
      • 19.3.8. End-use
      • 19.3.9. Country
        • 19.3.9.1. South Africa
        • 19.3.9.2. Egypt
        • 19.3.9.3. Nigeria
        • 19.3.9.4. Algeria
        • 19.3.9.5. Rest of Africa
    • 19.4. South Africa Pet Arthritis Treatment Market
      • 19.4.1. Country Segmental Analysis
      • 19.4.2. Product Type
      • 19.4.3. Animal Type
      • 19.4.4. Route of Administration
      • 19.4.5. Distribution Channel
      • 19.4.6. Treatment Stage
      • 19.4.7. Therapy Type
      • 19.4.8. Prescription Type
      • 19.4.9. End-use
    • 19.5. Egypt Pet Arthritis Treatment Market
      • 19.5.1. Country Segmental Analysis
      • 19.5.2. Product Type
      • 19.5.3. Animal Type
      • 19.5.4. Route of Administration
      • 19.5.5. Distribution Channel
      • 19.5.6. Treatment Stage
      • 19.5.7. Therapy Type
      • 19.5.8. Prescription Type
      • 19.5.9. End-use
    • 19.6. Nigeria Pet Arthritis Treatment Market
      • 19.6.1. Country Segmental Analysis
      • 19.6.2. Product Type
      • 19.6.3. Animal Type
      • 19.6.4. Route of Administration
      • 19.6.5. Distribution Channel
      • 19.6.6. Treatment Stage
      • 19.6.7. Therapy Type
      • 19.6.8. Prescription Type
      • 19.6.9. End-use
    • 19.7. Algeria Pet Arthritis Treatment Market
      • 19.7.1. Country Segmental Analysis
      • 19.7.2. Product Type
      • 19.7.3. Animal Type
      • 19.7.4. Route of Administration
      • 19.7.5. Distribution Channel
      • 19.7.6. Treatment Stage
      • 19.7.7. Therapy Type
      • 19.7.8. Prescription Type
      • 19.7.9. End-use
    • 19.8. Rest of Africa Pet Arthritis Treatment Market
      • 19.8.1. Country Segmental Analysis
      • 19.8.2. Product Type
      • 19.8.3. Animal Type
      • 19.8.4. Route of Administration
      • 19.8.5. Distribution Channel
      • 19.8.6. Treatment Stage
      • 19.8.7. Therapy Type
      • 19.8.8. Prescription Type
      • 19.8.9. End-use
  • 20. South America Pet Arthritis Treatment Market Analysis
    • 20.1. Key Segment Analysis
    • 20.2. Regional Snapshot
    • 20.3. South America Pet Arthritis Treatment Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 20.3.1. Product Type
      • 20.3.2. Animal Type
      • 20.3.3. Route of Administration
      • 20.3.4. Distribution Channel
      • 20.3.5. Treatment Stage
      • 20.3.6. Therapy Type
      • 20.3.7. Prescription Type
      • 20.3.8. End-use
      • 20.3.9. Country
        • 20.3.9.1. Brazil
        • 20.3.9.2. Argentina
        • 20.3.9.3. Rest of South America
    • 20.4. Brazil Pet Arthritis Treatment Market
      • 20.4.1. Country Segmental Analysis
      • 20.4.2. Product Type
      • 20.4.3. Animal Type
      • 20.4.4. Route of Administration
      • 20.4.5. Distribution Channel
      • 20.4.6. Treatment Stage
      • 20.4.7. Therapy Type
      • 20.4.8. Prescription Type
      • 20.4.9. End-use
    • 20.5. Argentina Pet Arthritis Treatment Market
      • 20.5.1. Country Segmental Analysis
      • 20.5.2. Product Type
      • 20.5.3. Animal Type
      • 20.5.4. Route of Administration
      • 20.5.5. Distribution Channel
      • 20.5.6. Treatment Stage
      • 20.5.7. Therapy Type
      • 20.5.8. Prescription Type
      • 20.5.9. End-use
    • 20.6. Rest of South America Pet Arthritis Treatment Market
      • 20.6.1. Country Segmental Analysis
      • 20.6.2. Product Type
      • 20.6.3. Animal Type
      • 20.6.4. Route of Administration
      • 20.6.5. Distribution Channel
      • 20.6.6. Treatment Stage
      • 20.6.7. Therapy Type
      • 20.6.8. Prescription Type
      • 20.6.9. End-use
  • 21. Key Players/ Company Profile
    • 21.1. Adequan (American Regent Animal Health)
      • 21.1.1. Company Details/ Overview
      • 21.1.2. Company Financials
      • 21.1.3. Key Customers and Competitors
      • 21.1.4. Business/ Industry Portfolio
      • 21.1.5. Product Portfolio/ Specification Details
      • 21.1.6. Pricing Data
      • 21.1.7. Strategic Overview
      • 21.1.8. Recent Developments
    • 21.2. Boehringer Ingelheim Animal Health
    • 21.3. Ceva Santé Animale
    • 21.4. Chanelle Pharma
    • 21.5. Dechra Pharmaceuticals PLC
    • 21.6. Elanco Animal Health
    • 21.7. Kindred Biosciences Inc.
    • 21.8. Merck Animal Health
    • 21.9. Nexvet Biopharma
    • 21.10. Norbrook Laboratories Limited
    • 21.11. Nutramax Laboratories Veterinary Sciences
    • 21.12. VetGen Pharmaceuticals
    • 21.13. Vetoquinol S.A.
    • 21.14. Virbac S.A.
    • 21.15. Zoetis Inc.
    • 21.16. Other Key Players

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Get PDF
PRICING DETAILS
USD 4150
USD 5950
USD 7750
Related Report  
YOU MAY ALSO LIKE
Algae Protein Market by Source Type, Form, Protein Content, Production Method, Nature, Extraction Technology, Grade, End-Use Industry, and Geography
Alternative Protein Market by Source/Type, Form, Product Type, Processing Technology, Distribution Channel, Protein Content, End-users, and Geography
Astaxanthin Market by Source/Origin, Form, Grade/Purity Level, Concentration Level, Production Technology, End-users, Distribution Channel, Packaging Type, and Geography
Discount On Multiple Reports

Where did We Help Most?

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation